Loss of Transketolase Promotes the Anti-Diabetic Role of Brown Adipose Tissues.

Yingning Ji,Wei Liu,Yemin Zhu,Yakui Li,Ying Lu,Qi Liu,Lingfeng Tong,Lei Hu,Nannan Xu,Zhangbing Chen,Na Tian,Lifang Wu,Lian Zhu,Shuang Tang,Ping Zhang,Xuemei Tong
DOI: https://doi.org/10.1530/joe-22-0047
2023-01-01
Journal of Endocrinology
Abstract:Transketolase (TKT), an enzyme in the non-oxidative branch of the pentose phosphate pathway (PPP), bi-directionally regulates the carbon flux between the PPP and glycolysis. Loss of TKT in adipose tissues decreased glycolysis and increased lipolysis and uncoupling protein-1 (UCP1) expression, protecting mice from high-fat diet-induced obesity. However, the role of TKT in brown adipose tissue (BAT)-dependent glucose homeostasis under normal chow diet remains to be elucidated. We found that TKT ablation increased levels of glucose transporter 4 (GLUT4), promoting glucose uptake and glycogen accumulation in BAT. Using the streptozotocin (STZ)-induced diabetic mouse model, we discovered that enhanced glucose uptake due to TKT deficiency in BAT contributed to decreasing blood glucose and weight loss, protecting mice from STZ-induced diabetes. Mechanistically, TKT deficiency decreased the level of thioredoxin-interacting protein, a known inhibitor for GLUT4, by decreasing NADPH and glutathione levels and inducing oxidative stress in BAT. Therefore, our data reveal a new role of TKT in regulating the anti-diabetic function of BAT as well as glucose homeostasis.
What problem does this paper attempt to address?